Holen Sie sich die Stockscreener-App
6.54
1.06%
-0.07
Handel nachbörslich:
6.54
Schlusskurs vom Vortag:
$6.61
Offen:
$6.46
24-Stunden-Volumen:
188.77K
Relative Volume:
1.24
Marktkapitalisierung:
$245.21M
Einnahmen:
$128.45M
Nettoeinkommen (Verlust:
$6.54M
KGV:
130.80
EPS:
0.05
Netto-Cashflow:
$-8.79M
1W Leistung:
-2.97%
1M Leistung:
-13.03%
6M Leistung:
+6.00%
1J Leistung:
+41.25%
1-Tages-Spanne:
$6.33
$6.67
1-Wochen-Bereich:
$6.33
$7.0099
52-Wochen-Spanne:
$4.51
$8.85
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Firmenname
Lifecore Biomedical Inc
Sektor
Telefon
(952) 368-4300
Adresse
3515 LYMAN BOULEVARD, CHASKA
Vergleichen Sie LFCR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
6.55 | 247.65M | 128.45M | 6.54M | -8.79M | 0.05 |
|
ZTS
Zoetis Inc
|
143.46 | 63.05B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.81 | 43.33B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.185 | 40.43B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.12 | 22.97B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
433.61 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-04 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-05-21 | Eingeleitet | William Blair | Outperform |
| 2024-09-05 | Eingeleitet | Craig Hallum | Buy |
| 2024-08-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | Herabstufung | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Aktie (LFCR) Neueste Nachrichten
Is it too late to sell Lifecore Biomedical Inc.Options Play & Free Community Supported Trade Ideas - newser.com
Will Lifecore Biomedical Inc. (LDE) stock deliver compounding returns2025 Trading Volume Trends & Weekly High Potential Alerts - newser.com
Why pension funds invest in Lifecore Biomedical Inc. (LDE) stock2025 Price Targets & Entry Point Confirmation Alerts - newser.com
How high can Lifecore Biomedical Inc. stock go2025 EndofYear Setup & Community Consensus Stock Picks - newser.com
Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events - GlobeNewswire
Best data tools to analyze Lifecore Biomedical Inc. stockPortfolio Risk Summary & Safe Swing Trade Setup Alerts - newser.com
What catalysts could drive Lifecore Biomedical Inc. stock higherWeekly Investment Report & Verified Swing Trading Watchlist - newser.com
Can Lifecore Biomedical Inc. stock beat market expectations this quarterSell Signal & Daily Oversold Stock Bounce Ideas - newser.com
3 Events: Lifecore to Present at PODD, CPHI Frankfurt & Pharma Outsourcing Summit Oct–Nov 2025 - Stock Titan
Is it time to cut losses on Lifecore Biomedical Inc.2025 Momentum Check & Smart Money Movement Tracker - newser.com
Will Lifecore Biomedical Inc. bounce back from current supportQuarterly Earnings Summary & High Yield Stock Recommendations - newser.com
Chart overlay techniques for tracking Lifecore Biomedical Inc.2025 Geopolitical Influence & Community Verified Trade Signals - newser.com
How Lifecore Biomedical Inc. (LDE) stock compares with market leadersTrade Entry Report & Fast Exit and Entry Strategy Plans - newser.com
Analyzing net buyer seller activity in Lifecore Biomedical Inc.2025 Risk Factors & Weekly Hot Stock Watchlists - newser.com
With 45% stake, Lifecore Biomedical, Inc. (NASDAQ:LFCR) seems to have captured hedge funds investors' interest - Yahoo Finance
Rating Downgrade: Lifecore, Ready To Go, But Problems Remain (NASDAQ:LFCR) - Seeking Alpha
CEO Insights: Industry Trends Driving Strong Tailwinds for U.S.-based CDMOs - Contract Pharma
Using fundamentals and technicals on Lifecore Biomedical Inc.Swing Trade & Weekly Watchlist for Hot Stocks - newser.com
Real time alert setup for Lifecore Biomedical Inc. performanceQuarterly Earnings Summary & Community Consensus Stock Picks - newser.com
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Published on: 2025-10-05 05:34:33 - newser.com
Lifecore granted Sector Weight rating at KeyBanc on growth trajectory - MSN
Can volume confirm reversal in Lifecore Biomedical Inc.Market Trend Report & AI Driven Price Forecasts - newser.com
Is Lifecore Biomedical Inc. (LDE) stock suitable for passive index funds2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
Quantitative breakdown of Lifecore Biomedical Inc. recent moveOil Prices & Real-Time Stock Entry Alerts - newser.com
LIFECORE SHAREHOLDER ALERT: Kaskela Law LLC Announces - GlobeNewswire
What drives Lifecore Biomedical Inc stock priceStock Buy Signals & Big Returns, Small Investment – Learn How - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Lifecore Biomedical Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView
What analysts say about Lifecore Biomedical Inc LDE stockStraddle and Strangle Trades & Free Stock Education Platform for New Investors - earlytimes.in
What analysts say about Lifecore Biomedical Inc stockMarket Correction Analysis & High Profit Market Growth - earlytimes.in
Is Lifecore Biomedical Inc a good long term investmentTechnical Analysis Insights & Learn to Trade with Real-Time Feedback - earlytimes.in
Finanzdaten der Lifecore Biomedical Inc-Aktie (LFCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.02%
2.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):